NeurologyLive® Friday 5 — September 8, 2023

Welcome to NeurologyLive^®'s Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive^®'s widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.

1: The Ever-Changing Management of Dyskinesia in Parkinson Disease

An expert panel discusses diagnosis and treatment of patients with Parkinson disease, exploring the challenges in managing dyskinesia, finding a balance between OFF episodes and ON time, and current and emerging treatment options.

2: Reasons for Attending 2023 American Neurological Association Annual Meeting: Rebecca Gottesman, MD, PhD, FANA; Frances E. Jensen, MD, FACP

The president of the ANA and the chair of the annual meeting programming committee provided perspective on the upcoming ANA Annual Meeting and what clinicians may get out of the meeting. [WATCH TIME: 7 minutes]

3: NeuroVoices: Sandeep Rana, MD, on Progress in Adult-Onset Spinal Muscular Atrophy

In this recent Q&A, the director of the ALS Clinic at Allegheny Health Network provided perspective on the advancements in the treatment and management of adult-onset spinal muscular atrophy.

4: Patient-Clinician Conversations Regarding Drug-Resistant Epilepsy, Surgical Options: Alex Whiting, MD

The director of epilepsy surgery at Allegheny Health Network provided insight on the early discussions between patients with drug resistant epilepsy and clinicians seeking to find beneficial treatment strategies. [WATCH TIME: 3 minutes]

5: Episode 97: Identifying Gaps in Access to Parkinson Disease Care

In our most recent Mind Moments Podcast episode, James Beck, PhD, senior vice president and chief scientific officer of the Parkinson's Foundation, provided perspective on a recently published Medicare claims study that highlighted major gaps and disparities in access to Parkinson disease care.